Steering New Drug Discovery Campaigns: Permeability, Solubility, and Physicochemical Properties in the bRo5 Chemical Space

被引:54
|
作者
Caron, Giulia [4 ]
Kihlberg, Jan [3 ]
Goetz, Gilles [1 ]
Ratkova, Ekaterina [2 ]
Poongavanam, Vasanthanathan [3 ]
Ermondi, Giuseppe [4 ]
机构
[1] Pfizer Inc, Discovery Sci, Hit Discovery & Optimizat, WWRD, Groton, CT 06340 USA
[2] AstraZeneca, Med Chem Res & Early Dev Cardiovasc Renal & Metab, BioPharmaceut R&D, Gothenburg, Sweden
[3] Uppsala Univ, Dept Chem BMC, SE-75123 Uppsala, Sweden
[4] Univ Torino, Mol Biotechnol & Hlth Sci Dept, I-10135 Turin, Italy
来源
ACS MEDICINAL CHEMISTRY LETTERS | 2021年 / 12卷 / 01期
关键词
Beyond rule of 5; intramolecular interaction; molecular chameleon; property-based drug design; virtual event; ACCELERATED MOLECULAR-DYNAMICS; PASSIVE MEMBRANE-PERMEABILITY; ORAL BIOAVAILABILITY; CELL-PERMEABILITY; RULE; PEPTIDE; MACROCYCLES; FLEXIBILITY; MODALITIES; ABSORPTION;
D O I
10.1021/acsmedchemlett.0c00581
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
An increasing number of drug discovery programs concern compounds in the beyond rule of 5 (bRo5) chemical space, such as cyclic peptides, macrocycles, and degraders. Recent results show that common paradigms of property-based drug design need revision to be applied to larger and more flexible compounds. A virtual event entitled "Solubility, permeability and physico-chemical properties in the bRo5 chemical space" was organized to provide preliminary guidance on how to make the discovery of oral drugs in the bRo5 space more effective. The four speakers emphasized the importance of the bRo5 space as a source of new oral drugs and provided examples of experimental and computational methods specifically tailored for design and optimization in this chemical space.
引用
收藏
页码:13 / 23
页数:11
相关论文
共 14 条
  • [1] Solubility prediction in the bRo5 chemical space: where are we right now?
    Ermondi, Giuseppe
    Poongavanam, Vasanthanathan
    Vallaro, Maura
    Kihlberg, Jan
    Caron, Giulia
    ADMET AND DMPK, 2020, 8 (03): : 207 - +
  • [2] Beyond the Rule of 5 (bRo5): The evolution of efficient drug discovery
    Lipinski, Christopher
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
  • [3] Refinement of Computational Access to Molecular Physicochemical Properties: From Ro5 to bRo5
    Sebastiano, Matteo Rossi
    Jimenez, Diego Garcia
    Vallaro, Maura
    Caron, Giulia
    Ermondi, Giuseppe
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, : 12068 - 12083
  • [4] Exploring biological and chemical space: the new dimension of drug discovery
    Blundell, T.
    FEBS JOURNAL, 2008, 275 : 23 - 23
  • [5] Updating the portfolio of physicochemical descriptors related to permeability in the beyond the rule of 5 chemical space
    Ermondi, Giuseppe
    Vallaro, Maura
    Goetz, Gilles
    Shalaeva, Marina
    Caron, Giulia
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 146
  • [6] The Impact of Physicochemical and Molecular Properties in Drug Design: Navigation in the "Drug-Like" Chemical Space
    Vallianatou, Theodosia
    Giaginis, Costas
    Tsantili-Kakoulidou, Anna
    GENEDIS 2014: NEURODEGENERATION, 2015, 822 : 187 - 194
  • [7] Flexibility in early drug discovery: focus on the beyond-Rule-of-5 chemical space
    Caron, Giulia
    Digiesi, Vito
    Solaro, Sara
    Ermondi, Giuseppe
    DRUG DISCOVERY TODAY, 2020, 25 (04) : 621 - 627
  • [8] Chemistry, Biosynthesis, Physicochemical and Biological Properties of Rubiadin: A Promising Natural Anthraquinone for New Drug Discovery and Development
    Watroly, Mohd Nasarudin
    Sekar, Mahendran
    Fuloria, Shivkanya
    Gan, Siew Hua
    Jeyabalan, Srikanth
    Wu, Yuan Seng
    Subramaniyan, Vetriselvan
    Sathasivam, Kathiresan, V
    Ravi, Subban
    Rani, Nur Najihah Izzati Mat
    Lum, Pei Teng
    Vaijanathappa, Jaishree
    Meenakshi, Dhanalekshmi Unnikrishnan
    Mani, Shankar
    Fuloria, Neeraj Kumar
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2021, 15 : 4527 - 4549
  • [9] Enamine REAL DataBase - an instrumental and practical vehicle for charting new regions of the relevant drug discovery chemical space
    Moroz, Yurii
    Chuprina, Alexander
    Mykytenko, Dmytro
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [10] Development and evaluation of Madin-Darby canine kidney (MDCK) monolayer permeability assay for profiling new chemical entities in early drug discovery
    Bansal, T.
    Singh, M. K.
    Jaggi, M.
    Talegaonkar, S.
    Khar, R. K.
    Mukherjee, R.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A46 - A46